IL-17 has emerged as a surprising arbiter of intestinal homeostasis on the basis of clinical observations of exacerbated IBD symptoms in patients with psoriasis treated with biologics that inhibit the IL-17 pathway13. This evidence concerns the gene IL17A and inflammatory bowel disease.